Michael Iannoni

Senior Accounting Manager at Xilio Therapeutics - Waltham, MA, US

Michael Iannoni's Colleagues at Xilio Therapeutics
Rachel Annese

Senior Clinical Trial Associate

Contact Rachel Annese

Daniel Lynch

Chairman Of The Board

Contact Daniel Lynch

Executive Assistant and Office Manager

Contact

Peter Igo

Laboratory Operations Manager

Contact Peter Igo

Bill Bent

Sr Mgr, Technical Accounting & Financial Reporting

Contact Bill Bent

Farrah Chaudhary

Senior Director CMC Operations

Contact Farrah Chaudhary

View All Michael Iannoni's Colleagues
Michael Iannoni's Contact Details
HQ
617-430-4762
Location
Boston, Massachusetts, United States
Company
Xilio Therapeutics
Michael Iannoni's Company Details
Xilio Therapeutics logo, Xilio Therapeutics contact details

Xilio Therapeutics

Waltham, MA, US • 100 - 249 Employees
BioTech/Drugs

Xilio is a Waltham, Massachusetts-based biopharmaceutical company focused on defeating cancer. The company's proprietary technology enables the explosion of therapeutic activity specifically within the tumor while reducing toxicity throughout the body – a nod to the company name, Xilio, derived from the Latin term, Ex Nihilo, meaning creation or big-bang. Xilio is applying its technology to build a broad pipeline of engineered antibodies, cytokines and chemokines as potential new options for people living with cancer. To learn more, please visit www.xiliotx.com.

N/A
Details about Xilio Therapeutics
Frequently Asked Questions about Michael Iannoni
Michael Iannoni currently works for Xilio Therapeutics.
Michael Iannoni's role at Xilio Therapeutics is Senior Accounting Manager.
Michael Iannoni's email address is ***@xiliotx.com. To view Michael Iannoni's full email address, please signup to ConnectPlex.
Michael Iannoni works in the BioTech/Drugs industry.
Michael Iannoni's colleagues at Xilio Therapeutics are Rachel Annese, Daniel Lynch, , Peter Igo, Bill Bent, Yu-Shan Stephanie, Farrah Chaudhary and others.
Michael Iannoni's phone number is 617-430-4762
See more information about Michael Iannoni